Animal study · mice
SS-31 partly undid age-related muscle phosphorylation in old mice
Checked against the paper Animal studyPublished by PepVault
The takeaway
In old female mice, elamipretide partly reversed some age-related protein tagging in muscle, which adds lab detail to the team's earlier mouse findings on muscle aging but says nothing yet about people.
- Kind
- Animal study
- Studied in
- Mice
- Published
- 2022
- Journal
- Geroscience
What they tested
The team tested whether 8 weeks of elamipretide changes protein phosphorylation (a chemical tag added to proteins) across skeletal muscle in old female mice, and whether those changes line up with S-glutathionylation, another protein tag.
How the study was done
An animal study comparing young female mice aged 6-7 months with old female mice aged 28-29 months, with old mice given elamipretide for 8 weeks. Phosphorylation was measured across muscle proteins as a whole.

What they found
In aged female mice, 8 weeks of elamipretide partly reversed the age-related changes in skeletal muscle protein phosphorylation. The shifts in phosphorylation did not track with the changes in S-glutathionylation. The same group had earlier found that 8 weeks of elamipretide improved muscle function and eased redox stress (an imbalance tied to oxidative damage) in old female mice.
What it doesn’t show
This was work in mice, so it is not a human result. Only female mice were studied, and this study centered on protein tags in muscle; the muscle function gains come from the team's earlier mouse work.
The paper
Campbell et al. Elamipretide effects on the skeletal muscle phosphoproteome in aged female mice. Geroscience. 2022.
The compound
More studies on SS-31
- SS-31 (elamipretide) eye drops missed main vision goal in LHON trialRandomized trial · people · 2024
- SS-31: wearable data grouped responders with 100% accuracyRandomized trial · people · 2023
- SS-31: no 12-week benefit, walk gains by 36 weeks open-labelRandomized trial · people · 2021
- SS-31 raised muscle ATP capacity after one dose in older adultsRandomized trial · people · 2021
- SS-31: walk distance rose with dose in 5-day MMPOWER trialRandomized trial · people · 2018
- SS-31: less kidney hypoxia after renal artery stenting in pilotRandomized trial · people · 2017
- Every study on SS-31
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.